Achieve Medical Device Regulatory Approval in Bolivia: A Step-by-Step Guide

Introduction

Manufacturers looking to enter Bolivia’s medical device market face a daunting regulatory maze that could either hinder their progress or pave the way for success. Grasping the complex regulations set by AGEMED is crucial for navigating compliance and securing market entry. As companies embark on this journey, they must confront pressing questions:

1. What strategies can they employ to navigate the approval process efficiently and avoid costly delays?

This guide offers a comprehensive roadmap for achieving medical device regulatory approval in Bolivia. Without a clear understanding of these regulations, companies risk costly delays and missed opportunities in a rapidly evolving market.

Understand the Regulatory Framework for Medical Devices in Bolivia

Navigating the complex medical device regulatory approval Bolivia process requires a deep understanding of the regulatory framework set by AGEMED, which is crucial for ensuring compliance and successful market entry. This agency manages the registration and market authorization of medical products, ensuring adherence to national health standards. Key regulations include:

• Law No. 1737: This law regulates the registration of medical products, including instruments, and outlines the requirements for market entry.
• Supreme Decree No. 001-2012: This decree offers comprehensive guidelines on the classification and registration processes for medical products.

Key Points to Consider:

• Device Classification: Medical devices in Bolivia are classified into four categories based on risk (Class I to IV). Understanding your apparatus’s classification is crucial as it determines the regulatory pathway and documentation required.
• Documentation Requirements: Prepare to submit a comprehensive technical dossier that includes product specifications, manufacturing methods, and clinical data if applicable. All documents must be in Spanish.
• Approval Timelines: The approval timeline can take anywhere from 12 to 24 months, depending on the device classification and the completeness of the submitted dossier. The pre-submission preparation phase can last from 1 to 4 months. Early involvement with the organization can help clarify specific requirements and expedite the process.
• Administrative Review: This phase lasts 1 to 2 months, where the organization checks for the completeness of the application.
• Technical/Scientific Review: This phase can take 6 to 16+ months, during which the organization evaluates the safety, efficacy, and quality of the product. Requests for Information (RFIs) may be issued for clarification.
• Marketing Authorizations: Valid for five years, these authorizations require renewal following the same procedures as the initial registration.

Having an experienced Local Authorized Representative (LAR) by your side can make navigating the medical device regulatory approval Bolivia much smoother and more efficient, ensuring compliance with all regulations and facilitating a smoother registration process. Without the guidance of an experienced Local Authorized Representative, the path to market entry for innovative medical products in Bolivia could become unnecessarily complicated and prolonged.

Prepare Your Medical Device for Submission

Successfully preparing your medical device for medical device regulatory approval in Bolivia requires a strategic approach to navigate complex regulations set by AGEMED. This process involves several critical steps to ensure compliance with medical device regulatory approval in Bolivia.

1. Compile the Technical Dossier: This dossier must include:

   • Device Description: Comprehensive details about the device, including its intended use and design specifications.
   • Manufacturing Information: Documentation of the manufacturing process, quality control measures, and relevant certifications.
   • Clinical Data: If applicable, results from clinical trials demonstrating the device’s safety and efficacy must be included.

2. Labeling Requirements: All labels and instructions for use must be in Spanish and adhere to local regulations. This includes:

   • Clear product identification
   • Usage instructions
   • Safety warnings

3. Quality Management System (QMS): Implement a QMS that aligns with international standards such as ISO 13485. This illustrates a dedication to quality and adherence, which is essential for obtaining approval.

4. Engaging local experts can significantly aid in achieving medical device regulatory approval in Bolivia, as hiring local regulatory consultants provides valuable insights into submission requirements and helps navigate potential challenges, ensuring a smoother pathway to approval. Their expertise can be particularly beneficial in understanding the nuances of the project’s requirements and expediting the process.

5. Pre-Submission Review: Conduct a thorough review of your submission materials to ensure completeness and accuracy before submitting to the relevant authority. Taking this step is crucial to prevent any delays from missing documents.

6. Approval Timeline: Be aware that the timeline for medical device regulatory approval in Bolivia can range from 12 to 24 months, depending on device classification, dossier quality, and AGEMED’s workload. Including buffer time in your market entry plans is advisable to account for potential delays. Navigating the regulatory landscape can be daunting for many companies, often leading to delays and complications. Leveraging Bioaccess’s insights into regulatory updates can help optimize this undertaking.

7. Free Sale Certificate (FSC): Ensure that a Free Sale Certificate is legalized, apostilled, and translated, as it is a key requirement for the submission of documents. This document proves that the product is legally sold in its home country.

By leveraging Bioaccess’s expertise, you can not only streamline your submission process but also enhance your chances of timely approval in a competitive market.

Navigate the Submission Process and Timelines

Navigating the medical device regulatory approval process in Bolivia can be daunting, yet understanding the critical steps can make all the difference.

1. Appoint a Local Authorized Representative (LAR): Before submitting your application, appoint a LAR who will act as your liaison with the relevant regulatory authority. This representative must be based in Bolivia and is responsible for all communications with the regulatory authority.

2. Submit the Application: Prepare and submit your application along with the technical dossier to the relevant authority. Ensure that all documents are complete and in Spanish to achieve medical device regulatory approval in Bolivia and avoid delays.

3. Review Process: AGEMED will review your submission, which typically takes:

   • Class I Devices: 1-3 months
   • Class II Devices: 3-6 months
   • Class III and IV Devices: 6-12 months

4. Stay Ready to Tackle Queries: Stay ready to tackle any questions or requests for more information from the organization without delay. Delays in response can extend the review timeline.

5. Approval Notification: Once you receive medical device regulatory approval in Bolivia from AGEMED, you’ll get a notification that enables you to market your product, but remember, compliance with post-approval requirements is crucial to avoid setbacks.

Manage Post-Approval Compliance and Market Strategies

Navigating the complexities of post-approval compliance can be daunting for medical device manufacturers, yet it is essential for sustained success in the market. After receiving approval for your medical device, managing post-approval compliance and developing effective market strategies becomes crucial.

1. Post-Market Surveillance: Implement a robust post-market surveillance system to monitor your product’s performance in the market. This means actively gathering and analyzing user feedback, reporting any adverse events to AGEMED, and conducting periodic reviews of device performance.
2. Regulatory Compliance: Ensure ongoing compliance with AGEMED regulations, including regular updates to your technical dossier as changes occur, compliance with labeling and advertising regulations, and adhering to any additional requirements set forth by AGEMED. Familiarize yourself with local regulatory authorities such as INVIMA, ANVISA, and COFEPRIS, which may have specific requirements for your device.
3. Market Strategies: Develop a comprehensive marketing strategy that includes identifying target markets and customer segments, establishing partnerships with local distributors and healthcare providers, engaging in educational initiatives to inform potential users about your device, and leveraging insights from Global Trial Accelerators™ to enhance your market access strategies.
4. Continuous Improvement: Use insights gained from post-market surveillance to inform product improvements and future submissions. This proactive approach can enhance your device’s market position and ensure long-term success, particularly in the dynamic landscape of Latin America. Ultimately, the ability to adapt and innovate in response to market feedback will determine your device’s success in a competitive landscape.

Conclusion

Navigating the complex regulatory landscape in Bolivia poses significant challenges for medical device manufacturers, making strategic planning essential for success. Grasping AGEMED’s framework, which includes device classification and documentation requirements, is crucial for a successful market entry. Thorough preparation, timely submissions, and strict adherence to compliance standards are vital to ensure innovative medical products reach the Bolivian market efficiently.

This guide underscores the necessity of:

• Appointing a Local Authorized Representative
• Compiling a comprehensive technical dossier
• Ensuring compliance with post-approval regulations

Every phase, from pre-submission preparation to post-market surveillance, is crucial for the success of the approval process. Engaging local experts and understanding the timelines involved will significantly reduce potential delays and enhance the chances of timely approval.

The path to medical device regulatory approval in Bolivia demands not only compliance but also a commitment to continuous improvement and market responsiveness. Leveraging insights from post-market data and adapting strategies accordingly will ensure sustained success in a competitive landscape. Embracing these best practices will streamline the approval process and position medical devices to make significant contributions to healthcare in Bolivia.

Frequently Asked Questions

What is the role of AGEMED in Bolivia’s medical device regulatory framework?

AGEMED is the regulatory agency responsible for managing the registration and market authorization of medical products in Bolivia, ensuring compliance with national health standards.

What are the key regulations governing medical devices in Bolivia?

The key regulations include Law No. 1737, which regulates the registration of medical products, and Supreme Decree No. 001-2012, which provides guidelines on the classification and registration processes for these products.

How are medical devices classified in Bolivia?

Medical devices in Bolivia are classified into four categories based on risk, ranging from Class I (low risk) to Class IV (high risk). This classification determines the regulatory pathway and documentation required for market entry.

What documentation is required for medical device registration in Bolivia?

A comprehensive technical dossier must be submitted, including product specifications, manufacturing methods, and clinical data if applicable. All documents must be in Spanish.

What is the typical timeline for medical device approval in Bolivia?

The approval timeline can take between 12 to 24 months, depending on the device classification and the completeness of the submitted dossier. The pre-submission preparation phase can last 1 to 4 months.

What are the phases involved in the approval process for medical devices?

The approval process includes an Administrative Review phase lasting 1 to 2 months to check application completeness, followed by a Technical/Scientific Review that can take 6 to 16+ months to evaluate safety, efficacy, and quality.

How long is the marketing authorization valid for medical devices in Bolivia?

Marketing authorizations are valid for five years and require renewal following the same procedures as the initial registration.

Why is having a Local Authorized Representative (LAR) important in Bolivia?

An experienced Local Authorized Representative can facilitate a smoother and more efficient registration process, ensuring compliance with all regulations and helping to navigate the complexities of the medical device regulatory framework in Bolivia.

List of Sources

1. Understand the Regulatory Framework for Medical Devices in Bolivia
   • omcmedical.com (https://omcmedical.com/blog/bolivia-medical-device-registration-process-timelines)
   • statista.com (https://statista.com/outlook/hmo/medical-technology/medical-devices/bolivia?srsltid=AfmBOops-OfLqQiWPvRVgwa4fADHww-d3OnV3LttzQo_ycmYpi5TFYly)
   • pharmaboardroom.com (https://pharmaboardroom.com/legal-reports/the-pharma-legal-handbook-bolivia)
2. Prepare Your Medical Device for Submission
   • omcmedical.com (https://omcmedical.com/blog/bolivia-medical-device-registration-process-timelines)
   • trade.gov (https://trade.gov/country-commercial-guides/bolivia-healthcare)
   • qreg.co.uk (https://qreg.co.uk/bolivia-regulatory-requirements)

{“@context”: “https://schema.org”, “@type”: “FAQPage”, “mainEntity”: [{“@type”: “Question”, “name”: “What is the role of AGEMED in Bolivia’s medical device regulatory framework?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “AGEMED is the regulatory agency responsible for managing the registration and market authorization of medical products in Bolivia, ensuring compliance with national health standards.”}}, {“@type”: “Question”, “name”: “What are the key regulations governing medical devices in Bolivia?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “The key regulations include Law No. 1737, which regulates the registration of medical products, and Supreme Decree No. 001-2012, which provides guidelines on the classification and registration processes for these products.”}}, {“@type”: “Question”, “name”: “How are medical devices classified in Bolivia?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Medical devices in Bolivia are classified into four categories based on risk, ranging from Class I (low risk) to Class IV (high risk). This classification determines the regulatory pathway and documentation required for market entry.”}}, {“@type”: “Question”, “name”: “What documentation is required for medical device registration in Bolivia?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “A comprehensive technical dossier must be submitted, including product specifications, manufacturing methods, and clinical data if applicable. All documents must be in Spanish.”}}, {“@type”: “Question”, “name”: “What is the typical timeline for medical device approval in Bolivia?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “The approval timeline can take between 12 to 24 months, depending on the device classification and the completeness of the submitted dossier. The pre-submission preparation phase can last 1 to 4 months.”}}, {“@type”: “Question”, “name”: “What are the phases involved in the approval process for medical devices?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “The approval process includes an Administrative Review phase lasting 1 to 2 months to check application completeness, followed by a Technical/Scientific Review that can take 6 to 16+ months to evaluate safety, efficacy, and quality.”}}, {“@type”: “Question”, “name”: “How long is the marketing authorization valid for medical devices in Bolivia?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Marketing authorizations are valid for five years and require renewal following the same procedures as the initial registration.”}}, {“@type”: “Question”, “name”: “Why is having a Local Authorized Representative (LAR) important in Bolivia?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “An experienced Local Authorized Representative can facilitate a smoother and more efficient registration process, ensuring compliance with all regulations and helping to navigate the complexities of the medical device regulatory framework in Bolivia.”}}]}{“@context”: “https://schema.org”, “@type”: “BlogPosting”, “headline”: “Achieve Medical Device Regulatory Approval in Bolivia: A Step-by-Step Guide”, “description”: “Navigate the complex process of medical device regulatory approval in Bolivia with our step-by-step guide.”, “datePublished”: “2026-04-24T00:00:42.553000”, “dateModified”: “2026-06-21T02:33:44.661354+00:00”, “articleBody”: “## Introduction\nManufacturers looking to enter Bolivia’s medical device market face a daunting regulatory maze that could either hinder their progress or pave the way for success. Grasping the complex regulations set by AGEMED is crucial for navigating compliance and securing market entry. As companies embark on this journey, they must confront pressing questions:\n\n1. What strategies can they employ to navigate the approval process efficiently and avoid costly delays?\n\nThis guide offers a comprehensive roadmap for achieving medical device regulatory approval in Bolivia. Without a clear understanding of these regulations, companies risk costly delays and missed opportunities in a rapidly evolving market.\n\n## Understand the Regulatory Framework for Medical Devices in Bolivia\n\nNavigating the complex [medical device regulatory approval Bolivia](https://bioaccessla.com/br/services) process requires a deep understanding of the regulatory framework set by AGEMED, which is crucial for ensuring [compliance and successful market entry](https://pharmaboardroom.com/legal-reports/the-pharma-legal-handbook-bolivia). This agency manages the registration and [market authorization of medical products](https://bioaccessla.com/blog/10-essential-medical-device-marketing-strategies-for-success), ensuring adherence to national health standards. Key regulations include:\n\n- Law No. 1737: This law regulates the registration of medical products, including instruments, and outlines the requirements for market entry.\n- Supreme Decree No. 001-2012: This decree offers comprehensive guidelines on the classification and registration processes for medical products.\n\nKey Points to Consider:\n\n- [Device Classification](https://bioaccessla.com/blog/10-class-2-medical-device-examples-for-clinical-research-leaders): Medical devices in Bolivia are classified into four categories based on risk (Class I to IV). Understanding your apparatus’s classification is crucial as it determines the regulatory pathway and documentation required.\n- [Documentation Requirements](https://bioaccessla.com/blog/10-essential-drugs-ending-in-mab-for-clinical-research): Prepare to submit a comprehensive technical dossier that includes product specifications, manufacturing methods, and clinical data if applicable. All documents must be in Spanish.\n- Approval Timelines: The approval timeline can take anywhere from 12 to 24 months, depending on the device classification and the completeness of the submitted dossier. The pre-submission preparation phase can last from 1 to 4 months. Early involvement with the organization can help clarify specific requirements and expedite the process.\n- Administrative Review: This phase lasts 1 to 2 months, where the organization checks for the completeness of the application.\n- Technical/Scientific Review: This phase can take 6 to 16+ months, during which the organization evaluates the safety, efficacy, and quality of the product. Requests for Information (RFIs) may be issued for clarification.\n- Marketing Authorizations: Valid for five years, these authorizations require renewal following the same procedures as the initial registration.\n\nHaving an experienced [Local Authorized Representative](https://bioaccessla.com/market-access) (LAR) by your side can make navigating the medical device regulatory approval Bolivia much smoother and more efficient, ensuring compliance with all regulations and facilitating a smoother registration process. Without the guidance of an experienced Local Authorized Representative, the path to market entry for innovative medical products in Bolivia could become unnecessarily complicated and prolonged.\n\n\n\n## Prepare Your Medical Device for Submission\n\nSuccessfully preparing your medical device for [medical device regulatory approval in Bolivia](https://bioaccessla.com/services) requires a strategic approach to navigate complex regulations set by AGEMED. This process involves several critical steps to ensure compliance with medical device regulatory approval in Bolivia.\n\n1. Compile the [Technical Dossier](https://qreg.co.uk/bolivia-regulatory-requirements): This dossier must include:\n\n – Device Description: Comprehensive details about the device, including its intended use and design specifications.\n – Manufacturing Information: Documentation of the manufacturing process, quality control measures, and relevant certifications.\n – [Clinical Data](https://bioaccessla.com/blog/10-clinical-research-organizations-transforming-medtech-innovation): If applicable, results from [clinical trials](https://bioaccessla.com/testimonials) demonstrating the device’s safety and efficacy must be included.\n2. [Labeling Requirements](https://bioaccessla.com/blog/10-essential-ethics-board-submission-templates-in-serbia): All labels and instructions for use must be in Spanish and adhere to local regulations. This includes:\n\n – Clear product identification\n – Usage instructions\n – Safety warnings\n3. [Quality Management System (QMS)](https://bioaccessla.com/solutions): Implement a QMS that aligns with international standards such as ISO 13485. This illustrates a dedication to quality and adherence, which is essential for obtaining approval.\n4. [Engaging local experts](https://bioaccessla.com/blog/10-benefits-of-clinical-trial-remote-monitoring-for-research-directors) can significantly aid in achieving medical device regulatory approval in Bolivia, as hiring local regulatory consultants provides valuable insights into submission requirements and helps navigate potential challenges, ensuring a smoother pathway to approval. Their expertise can be particularly beneficial in understanding the nuances of the project’s requirements and expediting the process.\n5. Pre-Submission Review: Conduct a thorough review of your submission materials to ensure completeness and accuracy before submitting to the relevant authority. Taking this step is crucial to prevent any delays from missing documents.\n6. [Approval Timeline](https://trade.gov/country-commercial-guides/bolivia-healthcare): Be aware that the timeline for medical device regulatory approval in Bolivia can range from 12 to 24 months, depending on device classification, dossier quality, and AGEMED’s workload. Including buffer time in your market entry plans is advisable to account for potential delays. Navigating the regulatory landscape can be daunting for many companies, often leading to delays and complications. Leveraging Bioaccess’s insights into regulatory updates can help optimize this undertaking.\n7. [Free Sale Certificate (FSC)](https://omcmedical.com/blog/bolivia-medical-device-registration-process-timelines): Ensure that a Free Sale Certificate is legalized, apostilled, and translated, as it is a key requirement for the submission of documents. This document proves that the product is legally sold in its home country.\n\nBy leveraging Bioaccess’s expertise, you can not only streamline your submission process but also enhance your chances of timely approval in a competitive market.\n\n\n\n## Navigate the Submission Process and Timelines\n\nNavigating the [medical device regulatory approval](https://bioaccessla.com/es/services) process in Bolivia can be daunting, yet understanding the critical steps can make all the difference.\n\n1. Appoint a [Local Authorized Representative (LAR)](https://bioaccessla.com/blog/10-key-insights-on-21-cfr-part-807-for-clinical-research-directors): Before submitting your application, appoint a LAR who will act as your liaison with the relevant [regulatory authority](https://bioaccessla.com/news). This representative must be based in Bolivia and is responsible for all communications with the regulatory authority.\n2. Submit the Application: Prepare and [submit your application](https://bioaccessla.com/br/testimonials) along with the [technical dossier](https://bioaccessla.com/blog/10-essential-edc-software-features-for-clinical-research-directors) to the relevant authority. Ensure that all documents are complete and in Spanish to achieve medical device regulatory approval in Bolivia and avoid delays.\n3. Review Process: AGEMED will review your submission, which typically takes:\n\n – Class I Devices: 1-3 months\n – Class II Devices: 3-6 months\n – Class III and IV Devices: 6-12 months\n4. Stay Ready to Tackle Queries: Stay ready to tackle any questions or requests for more information from the organization without delay. Delays in response can extend the review timeline.\n5. [Approval Notification](https://bioaccessla.com/blog/master-fda-guidance-on-medical-devices-key-insights-for-researchers): Once you receive medical device regulatory approval in Bolivia from AGEMED, you’ll get a notification that enables you to market your product, but remember, compliance with post-approval requirements is crucial to avoid setbacks.\n\n\n\n## Manage Post-Approval Compliance and Market Strategies\n\nNavigating the complexities of [post-approval compliance](https://bioaccessla.com/blog/10-essential-cdisc-standards-every-clinical-research-director-should-know) can be daunting for medical device manufacturers, yet it is essential for sustained success in the market. After receiving approval for your medical device, managing post-approval compliance and developing effective [market strategies](https://bioaccessla.com/resources) becomes crucial.\n\n1. [Post-Market Surveillance](https://bioaccessla.com/latin-america-medtech-research-site-search-and-selection): Implement a robust [post-market surveillance system](https://bioaccessla.com/blog/10-key-insights-on-serbias-role-in-eu-drug-approval-harmonization) to monitor your product’s performance in the market. This means actively gathering and analyzing user feedback, reporting any adverse events to AGEMED, and conducting periodic reviews of device performance.\n2. [Regulatory Compliance](https://bioaccessla.com/es/solutions): Ensure ongoing compliance with AGEMED regulations, including regular updates to your technical dossier as changes occur, compliance with labeling and advertising regulations, and adhering to any additional requirements set forth by AGEMED. Familiarize yourself with [local regulatory authorities](https://bioaccessla.com/blog/10-essential-medical-device-types-every-clinical-research-director-should-know) such as INVIMA, ANVISA, and COFEPRIS, which may have specific requirements for your device.\n3. Market Strategies: Develop a comprehensive marketing strategy that includes identifying target markets and customer segments, establishing partnerships with local distributors and healthcare providers, engaging in educational initiatives to inform potential users about your device, and leveraging insights from Global Trial Accelerators™ to enhance your market access strategies.\n4. Continuous Improvement: Use insights gained from post-market surveillance to inform product improvements and future submissions. This proactive approach can enhance your device’s market position and ensure long-term success, particularly in the dynamic landscape of Latin America. Ultimately, the ability to adapt and innovate in response to market feedback will determine your device’s success in a competitive landscape.\n\n\n\n## Conclusion\nNavigating the complex regulatory landscape in Bolivia poses significant challenges for medical device manufacturers, making strategic planning essential for success. Grasping AGEMED’s framework, which includes device classification and documentation requirements, is crucial for a successful market entry. Thorough preparation, timely submissions, and strict adherence to compliance standards are vital to ensure innovative medical products reach the Bolivian market efficiently. \n\nThis guide underscores the necessity of: \n- Appointing a Local Authorized Representative \n- Compiling a comprehensive technical dossier \n- Ensuring compliance with post-approval regulations \n\nEvery phase, from pre-submission preparation to post-market surveillance, is crucial for the success of the approval process. Engaging local experts and understanding the timelines involved will significantly reduce potential delays and enhance the chances of timely approval. \n\nThe path to medical device regulatory approval in Bolivia demands not only compliance but also a commitment to continuous improvement and market responsiveness. Leveraging insights from post-market data and adapting strategies accordingly will ensure sustained success in a competitive landscape. Embracing these best practices will streamline the approval process and position medical devices to make significant contributions to healthcare in Bolivia.\n\n::iframe[https://iframe.tely.ai/cta/eyJhcnRpY2xlX2lkIjogIjY5ZWFiMmFhNzZmZTBkYzljMjIxMmRjZiIsICJjb21wYW55X2lkIjogIjY2OTk4NmYwMzM1YWQwNDI3ZTVmNTdlMyIsICJpbmRleCI6IG51bGwsICJ0eXBlIjogImFydGljbGUifQ==]{width=\”100%\” height=\”300px\”}”, “image”: [“https://images.tely.ai/telyai/deztvqwr-each-box-represents-a-step-in-the-approval-process-follow-the-arrows-to-see-how-each-phase-leads-to-the-next-from-classifying-your-device-to-obtaining-marketing-authorization.webp”, “https://images.tely.ai/telyai/yqzspsvu-each-box-represents-a-step-in-the-submission-process-follow-the-arrows-to-see-how-each-step-leads-to-the-next-ensuring-you-complete-all-necessary-actions-for-a-successful-submission.webp”, “https://images.tely.ai/telyai/uilllliv-each-box-represents-a-step-in-the-submission-process-follow-the-arrows-to-see-how-to-navigate-from-appointing-a-representative-to-receiving-approval.webp”, “https://images.tely.ai/telyai/kudczyoc-each-box-represents-a-crucial-step-in-the-process-follow-the-arrows-to-see-how-each-step-leads-to-the-next-guiding-you-through-the-complexities-of-compliance-and-market-strategy.webp”], “inLanguage”: “en”, “author”: {“@type”: “Organization”, “name”: “bioaccess®”}, “publisher”: {“@type”: “Organization”, “name”: “bioaccess®”, “url”: “https://bioaccessla.com”}}